Skip to Main content Skip to Navigation
Journal articles

TRPV4: new therapeutic target for inflammatory bowel diseases.

Abstract : The transient receptor potential vanilloid-4 (TRPV4) belongs to a family of ion channels and can be activated by warm temperature, hypotonicity, cell swelling or lipid mediators of the arachidonic cascade. The metabolites or events responsible for TRPV4 activation are associated with inflammation, arguing in favor of a role for this receptor in inflammatory diseases. The first studies have focused their attention on the role of TRPV4 in neurons and endothelial cells but TRPV4 cellular distribution is widespread, particularly in the gastrointestinal tract. Herein, we review a number of studies demonstrating the expression of TRPV4 in the gut, the regulation of its expression and functions by inflammatory mediators in that organ and the consequences of TRPV4 activation or inhibition in the intestine. We further discuss the relevance of considering this receptor as a potential target for therapeutic development in inflammatory bowel diseases.
Complete list of metadatas

Cited literature [41 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00975985
Contributor : Nathalie Vergnolle <>
Submitted on : Wednesday, April 9, 2014 - 2:15:54 PM
Last modification on : Tuesday, February 18, 2020 - 3:32:02 PM
Long-term archiving on: : Monday, April 10, 2017 - 11:36:09 AM

File

BioPharma_2014-TRPV4_and_IBD.p...
Files produced by the author(s)

Identifiers

Collections

Citation

Nathalie Vergnolle. TRPV4: new therapeutic target for inflammatory bowel diseases.. Biochemical Pharmacology, Elsevier, 2014, 89 (2), pp.157-61. ⟨10.1016/j.bcp.2014.01.005⟩. ⟨inserm-00975985⟩

Share

Metrics

Record views

1711

Files downloads

1132